EX-16.1 2 tm2421372d1_ex16-1.htm EXHIBIT 16.1

 

Exhibit 16.1

 

August 12, 2025

 

Securities and Exchange Commission
100 F Street, N.E.

Washington, DC 20549

 

Commissioners:

 

We have read the statements made by Marker Therapeutics, Inc. under Item 4.01 of its Form 8-K dated August 7, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Marker Therapeutics, Inc. contained therein.

 

Very truly yours,

 

/s/ Marcum LLP

 

Marcum LLP CityPlace I / 185 Asylum Street / 25th Floor / Hartford, CT 06103 / Phone 860.760.0600 marcumllp.com